Ieiri Ichiro | Department Of Clinical Pharmacokinetics Graduate School Of Pharmaceutical Sciences Kyushu University

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Polymorphism of MDR1 Gene in healthy Japanese Subjects : A Novel SNP with an Amino Acid Substitution (Glu108Lys)
Contribution of Angiotensin Converting Enzyme Gene Polymorphism to the Action of Angiotensin II Receptor Antagonist (CS-866)
Dubin-Johnson 症候群患者に認めたABCC2遺伝子の部分欠損(exon 7 全域)例
FORMATION OF HIGHLY ANALGESIC MORPHINE-6-GLUCURONIDE FOLLOWING PHYSIOLOGIC CONCENTRATION OF MORPHINE IN HUMAN BRAIN
Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism
Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin
Pharmacogenetic determinants of variability in lipid-lowering response to pravastatin therapy
Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects
The Effects of Genetic Polymorphisms of CYP2C9 and CYP2C19 on Phenytoin Metabolism in Japanese Adult Patients with Epilepsy : Studies in Stereoselective Hydroxylation and Population Pharmacokinetics
The effect of 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) enantiomers, major metabolites of phenytoin, on the occurrence of chronic side effects : In vivo and in vitro studies
Drug interactions of zonisamide with phenytoin and sodium valproate: serum cncentrations and protein binding
The Effect of Phenytoin Withdrawal on Valproic Acid Free Fraction : A Case Report
Dosing Time-Dependency of the Arthritis-Inhibiting Effect of Tacrolimus in Mice
Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure
Predictive performance of Bayesian method in a simulation work: One-compartment open linear model containing an oral route.

もっと見る

スポンサーリンク